| Authors: |
Dapper H; Department of Radiation Oncology, Cyberknife and Radiation Therapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. hendrik.dapper@uk-koeln.de., Oertel M; Department of Radiation Oncology, University Hospital Münster, Münster, Germany.; West German Cancer Center Münster (WTZ), University Hospital Münster, Münster, Germany., Vorwerk H; Department of Radiation Therapy and Oncology, UKGM GmbH, University Hospital Marburg, Faculty of Medicine, Philipps-University of Marburg, Marburg, Germany., Drabke S; Department of Radiation Oncology, University Medical Center Mainz, Mainz, Germany., Steinmann D; Department of Radiotherapy, Hannover Medical School, Hannover, Germany., Fokas E; Department of Radiation Oncology, Cyberknife and Radiation Therapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Schmidberger H; Department of Radiation Oncology, University Medical Center Mainz, Mainz, Germany., Wielenberg NE; Department of Radiation Oncology, Medical Center University of Freiburg, Medical Faculty University of Freiburg, Freiburg, Germany., Mäurer M; Department of Radiation Oncology, Jena University Hospital, Jena, Germany., Linde P; Department of Radiation Oncology, Cyberknife and Radiation Therapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. |
